Latest Boston News | Page 2

Police Involvement May Hamstring Overdose Outreach Efforts
Chemists build synthetic catalysts to break down biomass like super enzymes
Moderna’s New Centre To Accelerate mRNA Research
Using broad race categories in medicine hides true health risks
Cornell Cares: Making difference in your hometown
Run-of-the-mill day for officer
A window into the brain provides clues for improving the wellbeing of children born very preterm
Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies
Soliris approved in the EU for children and adolescents with refractory generalised myasthenia gravis (gMG)
Apple and MLB announce August “Friday Night Baseball” schedule on Apple TV+
Australia must look to Canada for world’s best-practice in digital health
FASTEST MARATHON FIELD ASSEMBLED IN AUSTRALIAN HISTORY FOR SYDNEY MARATHON
CBA invests in global climate specialist Wollemi Capital
Monash University buys CSIRO’s Parkville property; Australia’s biomedical research sector set to expand
Powerhouse poet heading to Edinburgh Fringe Festival
A Dog’s Breed Can Affect Pain Sensitivity, But Not Necessarily The Way Your Vet May Think
Researchers make a quantum computing leap with a magnetic twist
Do Children Inherit Parents’ Stressful Experiences?
Soliris recommended for approval in the EU by CHMP for children and adolescents with refractory generalised myasthenia gravis (gMG)
Restoring Sight in Patients at Home and Abroad
Scientists have created synthetic human embryos. Now we must consider the ethical and moral quandaries
Sydney Marathon sets the stage for Australia’s largest ever marathon
Soliris approved in China for treatment of adults with refractory generalised myasthenia gravis
THREDing together new approach to eating disorders
UQ forges global partnership to create home-grown vaccines
Aravax launches new Phase 2 trial of peanut allergy candidate
Qld’s booming biomedical sector hits world stage in Boston  
Addressing the Oral Health Needs of People Living with HIV/AIDS
Baseball reveals that specialists excel after leaving comfort zones
Game design initiative makes digital dreams come true
Principals headed to Harvard University after receiving coveted scholarships
Ultomiris approved in Japan for the prevention of relapses in patients with neuromyelitis optica spectrum disorder (NMOSD)
‘We Are So Sick as a Nation’: Food is Medicine Summit Puts Focus on Nutrition
International Day of Plant Health puts plant biosecurity under the microscope
Ultomiris approved in the EU for adults with neuromyelitis optica spectrum disorder (NMOSD)
Scientists develop AI tool to predict Parkinson’s disease onset
Here’s how a new AI tool may predict early signs of Parkinson’s disease
Koselugo approved in China for paediatric patients with neurofibromatosis type 1 and plexiform neurofibromas
Fatema Rampurawala: intern extraordinaire
Matias Aranguiz, EG23
Leading Universities and Investors Launch Set of Recommendations for the Innovation Sector
Ten days of eating and drinking experiences start today across South Australia
NEURO-TTRansform Phase III results presented at AAN showed eplontersen demonstrated consistent and sustained improvement in all measures of disease and quality of…
Microsoft and Epic expand strategic collaboration with integration of Azure OpenAI Service
ARA and CEW launch 2023 Women Leaders in Retail scholarship
Running gels and protein powders can be convenient boosts for athletes – but be sure to read the label
Triennial To Bring World Of Art And Design To NGV
Medicare non-compliance and fraud costing Australians